Back to Search Start Over

Squaramides enhance NLRP3 inflammasome activation by lowering intracellular potassium.

Authors :
Seoane PI
Beswick JA
Leach AG
Swanton T
Morris LV
Couper K
Lowe M
Freeman S
Brough D
Source :
Cell death discovery [Cell Death Discov] 2023 Dec 22; Vol. 9 (1), pp. 469. Date of Electronic Publication: 2023 Dec 22.
Publication Year :
2023

Abstract

The NLRP3 inflammasome is a component of the inflammatory response to infection and injury, orchestrating the maturation and release of the pro-inflammatory cytokines interleukin-1β (IL-1β), IL-18, and triggering pyroptotic cell death. Appropriate levels of NLRP3 activation are needed to avoid excessive tissue damage while ensuring host protection. Here we report a role for symmetrical diarylsquaramides as selective K <superscript>+</superscript> efflux-dependent NLRP3 inflammasome enhancers. Treatment of macrophages with squaramides potentiated IL-1β secretion and ASC speck formation in response to K <superscript>+</superscript> efflux-dependent NLRP3 inflammasome activators without affecting priming, endosome cargo trafficking, or activation of other inflammasomes. The squaramides lowered intracellular K <superscript>+</superscript> concentration which enabled cells to respond to a below-threshold dose of the inflammasome activator nigericin. Taken together these data further highlight the role of ion flux in inflammasome activation and squaramides as an interesting platform for therapeutic development in conditions where enhanced NLRP3 activity could be beneficial.<br /> (© 2023. The Author(s).)

Details

Language :
English
ISSN :
2058-7716
Volume :
9
Issue :
1
Database :
MEDLINE
Journal :
Cell death discovery
Publication Type :
Academic Journal
Accession number :
38129373
Full Text :
https://doi.org/10.1038/s41420-023-01756-9